4502 On Other Exchanges
Symbol
Exchange
4502 is not on other exchanges.

Executive Profile*

William W. Chin M.D.

Member of Takeda Global Advisory Board,Takeda Pharmaceutical Company Limited
AgeTotal Calculated CompensationThis person is connected to 71 board members in 5 different organizations across 7 different industries.

See Board Relationships
----

Background*

Dr. William W. Chin, M.D. serves as an Executive Dean at Research, Bertarelli Professor for Translational Medical Science and Professor of Medicine at Harvard Medical School (HMS). Dr. Chin served as Senior Vice President of Discovery & Clinical Research at Eli Lilly and Company. Dr. Chin served as the Vice President of Discovery Biology Research and Clinical Investigation of Eli Lilly and Company since July 2003. Dr. Chin served as Vice President of gene regulation, ...

Read Full Background

Corporate Headquarters*

12-10, Nihonbashi 2-chome
Osaka, -- 103-8668

Japan

Phone: 81 3 3278 2111
Fax: 81 3 3278 2000

Board Members Memberships*

Director
Director

Education*

BA 1968
Columbia College
MD 1972
Harvard Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Becton, Dickinson and Company
$1.0M
Miles D. White Chairman of The Board, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
José E. Almeida Chairman and Chief Executive Officer
Baxter International Inc.
$231.5K
Lars Rebien Sørensen Chief Executive Officer, President and Chairman of Operations Committee
Novo Nordisk A/S
kr21.2M
Stefan Oschmann Chairman of Executive Board, Chief Executive Officer and Chairman of Corporate Responsibility Committee
Merck KGaA
€5.4M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.